Firefly BioWorks Inks $2M
Firefly BioWorks Inc., a developer of instrument-independent multiplexed assays, has raised $2 million in fresh capital. The company did not disclose the names of investors, but said it would use the infusion to support its commercial strategy. Firefly BioWorks is based in Cambridge, Mass.
24 October 2011•2 mins read
